Newsletter | September 24, 2024

09.24.24 -- Does Targeting Macrophages Hold The Key For Treating Cancer?

SPONSOR

Webinar: Enabled Form Selection for Oral Drug Products Using a Combination of In-Silico Modeling and In-Vitro Measurements

This webinar highlights the use of PBPK modeling software like GastroPlus® to simulate drug properties and interactions, reducing unnecessary testing. We'll cover solid form screening, formulation maps for amorphous solid dispersions, and criteria for salt screening, emphasizing how these tools can guide early drug form selection and enhance bioavailability. Register now to learn more.

FEATURED EDITORIAL

Does Targeting Macrophages Hold The Key For Treating Cancer?

A conversation with Roy Maute, Ph.D., Pheast Therapeutics

What is the role of macrophages, macrophage checkpoint inhibitors, and targeting immune receptor CD24 in treating cancer?

INDUSTRY INSIGHTS

When Measuring Filter Performance, Is Performance Absolute?

Article | By Mark Ayles, Cytiva

Learn why high-performing filters are inadequate for critical filtration processes and sterilizing-grade filters are necessary to effectively remove undesirable species, including bacteria and viruses.

Particle Engineering For Inhalation Drug Delivery

Application Note | By Matthew Ferguson, Lonza

Explore key parameters for choosing the right particle engineering approach to meet dry powder inhaler (DPI) target product profiles for inhalation-based drug products.

Key Stages In mRNA-Based Therapeutic Development

White Paper | Precision NanoSystems

Learn how planning a product development strategy early on with a technology partner who has deep expertise and technical knowledge of genomic medicines can address uncertainties from the outset.

Utilizing Nanoparticle Technologies For A More Sustainable Value Chain

e-book | Nanoform

The pharma industry is identifying ways to make processes more sustainable. Learn how nanoparticle engineering technology can both empower sustainability goals and lead to better patient outcomes.

First-In-Human Services To Streamline End-To-End Development

White Paper | Lonza

Lonza’s SimpliFiH Solutions offering is designed to simplify and accelerate the development pathway, even for APIs with challenging properties, such as low aqueous solubility and poor bioavailability.

Investing In Capacity – API Commercial Manufacturing

Case Study | Cambrex

A pharma company sought a CMO partner with commercial manufacturing capabilities and expertise as well as exemplary quality systems to find a cost-effective process to produce the API for a new drug.

SPONSOR

Explore the forefront of precision medicine at the Advancing Precision Medicine Conference and Exhibition in Philadelphia, November 1-2. Engage with cutting-edge research featuring experts who are shaping the future of healthcare. Discover new insights into personalized treatments, genomic advancements, and innovative technologies revolutionizing patient care. Expand your knowledge and network with leaders driving the field forward. View the agenda and register today!